← Back to directory

Oliver A. Cornely

Researcher Next ID · RN-034064

Researcher · Medicine

TH Köln - University of Applied Sciences

Cologne, Switzerland

Accepting doctoral researchersFunding unknown
Works count
1,056
Citation count
58,189
H-index
113
i10-index
544

Research interests

Medicine
Veterinary
Antifungal resistance and susceptibility
Fungal Infections and Studies
Neutropenia and Cancer Infections
Infectious Diseases and Mycology
Nail Diseases and Treatments

Publications

  • Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

    The Lancet Infectious Diseases · 2025 · https://doi.org/10.1016/s1473-3099(24)00749-7

  • Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM

    The Lancet Infectious Diseases · 2024 · https://doi.org/10.1016/s1473-3099(23)00731-4

  • Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses

    European Respiratory Journal · 2024 · https://doi.org/10.1183/13993003.00061-2024

  • Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

    The Lancet Infectious Diseases · 2023 · https://doi.org/10.1016/s1473-3099(22)00872-6

  • Tackling the emerging threat of antifungal resistance to human health

    Nature Reviews Microbiology · 2022 · https://doi.org/10.1038/s41579-022-00720-1

  • The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

    Kölner Universitäts PublikationsServer (Universität zu Köln) · 2022

  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

    The Lancet Infectious Diseases · 2021 · https://doi.org/10.1016/s1473-3099(20)30784-2

  • Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology

    The Lancet Infectious Diseases · 2021 · https://doi.org/10.1016/s1473-3099(21)00191-2

  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

    Intensive Care Medicine · 2020 · https://doi.org/10.1007/s00134-020-06091-6

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

    The Lancet Infectious Diseases · 2020 · https://doi.org/10.1016/s1473-3099(20)30847-1

  • Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19

    Immunity · 2020 · https://doi.org/10.1016/j.immuni.2020.11.016

  • Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans

    Cell · 2019 · https://doi.org/10.1016/j.cell.2019.01.041

  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    The Lancet Infectious Diseases · 2019 · https://doi.org/10.1016/s1473-3099(19)30312-3

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    Clinical Microbiology and Infection · 2018 · https://doi.org/10.1016/j.cmi.2018.01.002

  • Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus

    mSphere · 2017 · https://doi.org/10.1128/msphere.00238-17

  • ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    Clinical Microbiology and Infection · 2014 · https://doi.org/10.1111/1469-0691.12371

  • ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

    Clinical Microbiology and Infection · 2014 · https://doi.org/10.1111/1469-0691.12465

  • ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

    Clinical Microbiology and Infection · 2014 · https://doi.org/10.1111/1469-0691.12515

  • ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

    Clinical Microbiology and Infection · 2013 · https://doi.org/10.1111/1469-0691.12360

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

    Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12040

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

    Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12038

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

    Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12039

  • Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

    New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa061094

  • Antimicrobial therapy of unexplained fever in neutropenic patients

    Annals of Hematology · 2003 · https://doi.org/10.1007/s00277-003-0764-4

Current projects

    No projects listed.